Skip to main content
TipRanks
Go Ultimate75% OFF

Lifeist Wellness (LFST) AI Stock Analysis

250 Followers
TSE:LFST

Lifeist Wellness

(TSXV:LFST)

Select Model
Rating:39Underperform
Price Target:CAD 0.04â–²(7.50% Upside)
Action:reiterated
Date:11/06/26

The overall score is severely depressed by the company's precarious financial state, marked by collapsing revenues, negative gross margins, and ongoing cash burn. Technicals reinforce the weakness with the stock trading below all major moving averages and exhibiting negative momentum. The low P/E ratio is a value trap given the lack of core earnings power. The absence of debt is the sole positive but is insufficient to offset the high risk of financial distress.

Positive Factors
Zero DebtReportedly zero debt reduces fixed financial obligations and refinancing exposure, giving Lifeist more flexibility than a highly leveraged peer. This provides some balance-sheet resilience while management addresses weak operations, although it does not offset cash burn.
Negative Factors
Severe Revenue CollapseThe dramatic multi-year revenue contraction signals a materially smaller operating base and weak commercial traction. Such a reduced scale limits the company’s ability to absorb costs, fund product development, and rebuild a sustainable growth platform over the next several quarters.

Lifeist Wellness (LFST) vs. iShares MSCI Canada ETF (EWC)

-50%-40%-30%-20%-10%0%10%20%30%TSE:LFST-38.46%EWC+11.69%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
CAD 1.52M
Dividend Yield
―
Average Volume (3M)
43.41K
Price to Earnings (P/E)
9.5
Beta (1Y)
0.90
Revenue Growth
-87.74%
EPS Growth
-220.61%
Country
Canada
Employees
72
Sector
Consumer Defensive
Sector Strength
62
Industry
Medical - Pharmaceuticals

Lifeist Wellness Business Overview & Revenue Model

Company Description

Headquartered in Vancouver, Canada, and established in 2005, Lifeist Wellness Inc. (formerly Namaste Technologies Inc. until September 2021) operates as a multifaceted wellness enterprise across the United States and Canada. Its diverse portfolio inc...

How the Company Makes Money

Lifeist generates revenue primarily through sales made by its operating subsidiaries. Key revenue streams have historically included (1) consumer wellness product sales (e.g., plant-based/alternative wellness products sold through wholesale, retail,...

Lifeist Wellness Financial Statement Overview

Summary

Financial health is critically weak. Revenue has collapsed, gross profit is negative, and operating losses persist. The company is burning cash with negative operating and free cash flow. The only mitigating factor is a debt-free balance sheet, but thin and shrinking equity raises solvency concerns.

Income Statement

8Very Negative

Balance Sheet

18Very Negative

Cash Flow

7Very Negative
Financial statement breakdown
BreakdownTTMFeb 2026Feb 2025Feb 2024Feb 2023Feb 2022
Income Statement
Total Revenue281.14K249.37K588.80K21.66M22.07M21.15M
Gross Profit-321.93K-845.37K204.75K5.34M3.79M120.29K
EBITDA-1.60M-2.39M-3.99M-5.96M-17.44M-20.25M
Net Income3,858-2.99M-1.45M-14.13M-15.44M-23.80M
Balance Sheet
Total Assets1.14M1.84M5.13M13.40M20.67M37.96M
Cash, Cash Equivalents and Short-Term Investments74.15K781.81K2.34M1.45M3.80M12.74M
Total Debt0001.27M328.33K554.59K
Total Liabilities408.67K688.62K1.06M9.94M7.30M11.89M
Stockholders Equity730.50K1.15M4.07M3.46M13.36M26.06M
Cash Flow
Free Cash Flow-1.56M-2.90M-877.20K-2.79M-16.04M-18.64M
Operating Cash Flow-1.56M-2.90M-877.20K-2.46M-15.35M-18.28M
Investing Cash Flow665.12K1.34M1.92M1,2776.69M-229.57K
Financing Cash Flow00-169.19K83.82K-252.29K21.02M

Lifeist Wellness Technical Analysis

Technical Analysis SentimentNegative
Last Price0.04

Price Trends

50DMA0.04Negative
100DMA0.05Negative
200DMA0.05Negative

Market Momentum

MACD-0.00Positive
RSI45.48Neutral
STOCH17.78Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:LFST, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.04, below the 50-day MA of 0.04, and below the 200-day MA of 0.05, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 45.48 is Neutral, neither overbought nor oversold. The STOCH value of 17.78 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:LFST.

Lifeist Wellness Peers Comparison

Overall Rating

UnderperformOutperform
Sector (62)

Financial Indicators

TSE:LFST against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *62Neutral$20.33B14.63-3.31%3.23%1.93%-12.26%
TSE:LFSTTSE:LFST39UnderperformCAD 1.52M9.520.38%―-87.74%-220.61%
TSE:MGWTSE:MGW21UnderperformCAD 969.81K-1.327.55%――-141.90%

* Consumer Defensive Sector Average

Performance Comparison

-40%-20%0%TSE:LFSTTSE:MGWTSE:TCANDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TSE:LFST and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TSE:LFSTLifeist Wellness Inc0.04-0.02-33.33%
TSE:MGWMaple Leaf Green World0.030.000.00%
TSE:TCANTranscanna Holdings0.010.000.00%

Lifeist Wellness Corporate Events

Business Operations and StrategyRegulatory Filings and Compliance

Lifeist Wellness Adopts Semi-Annual Reporting Under Venture Issuer Exemption

Neutral
Oct 14, 2026

Lifeist Wellness Inc. has opted to move to a semi-annual financial reporting schedule under a Canadian coordinated blanket order that permits certain venture issuers to reduce the frequency of their interim filings. With a fiscal year ending November...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 06, 2026